Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal
Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer
Tyrosine Kinase Inhibitor Encoraging For NSCLC
Novel Agents Promise Relief From Hematologic Side Effects
Interferon Alpha-2B Effective For Malignant Melanoma
International Group Plans Survey On Thrombosis Risk
NCI-Approved Clinical Trials Listed For June 2001
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore









